The Virustatic Shield has been designed and developed to reduce pathogenic microbial intake into the human respiratory system. Its revolutionary Viruferrin™ protein coating works to disable viruses on contact to help slow the spread of infections. This was originally proven during testing against the H1N1 Influenza virus in June 2020, laboratory tests by independent scientists from VisMederi at the University of Siena have also found that the Viruferrin™ protein compound inhibits SARS-CoV-2 at a cellular level. This is the exact strain behind Covid-19.
The ‘snood’ style design is lightweight and can be worn with comfort for many more hours than current closely fitted face masks. It is reusable and effective for up to 200 hours and retains its protective layer for up to 3 washes. In addition, the protein layer is designed to allow the mask to be touched without transferring the virus for non-hazardous disposal once used.
The Virustatic Shield is an anti-viral face covering with protective features. It has been designed to provide protection against viruses and has been proven to be over 96% effective against the H1N1 influenza virus. In June 2020, laboratory tests by independent scientists from VisMederi at the university of Siena found that the Viruferrin™ protein compound inhibits SARS-CoV-2 at a cellular level. This is the exact strain behind Covid-19. This Shield is the only face covering available that has a protective Viruferrin™ coating. Please note, no device can guarantee 100% protection against viruses. The Virustatic Shield effectiveness is improved when used alongside the World Health Organization (WHO) issued hygiene guidelines.
*For all UKCS oil and gas operatives, please visit our Virustatic Shield - UKCS Helicopter Operator webpage